Serum levels of monocyte chemotactic protein‐3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis

類似資料

• Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis
  著者:: Hasegawa, M, 等
  出版事項: (2004)
• B-Lymphocyte Depletion Reduces Skin Fibrosis and Autoimmunity in the Tight-Skin Mouse Model for Systemic Sclerosis
  著者:: Hasegawa, Minoru, 等
  出版事項: (2006)
• Raised monocyte chemotactic protein‐1 (MCP‐1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus
  著者:: Iikuni, N, 等
  出版事項: (2006)
• Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α) and MIP-1β) in patients with systemic sclerosis: MCP-1 and MIP-1α may be involved in the development of pulmonary fibrosis
  著者:: HASEGAWA, M, 等
  出版事項: (1999)
• Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis
  著者:: Yanaba, K, 等
  出版事項: (2004)